Trevi Therapeutics
TRVI
TRVI
23 hedge funds and large institutions have $32.9M invested in Trevi Therapeutics in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23.23% less ownership
Funds ownership: 50.95% → 27.72% (-23%)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.39M | |
| 2 | +$154K | |
| 3 | +$81K | |
| 4 |
UBV
United Bank (Virginia)
Vienna,
Virginia
|
+$59K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$52.1K |
Top Sellers
| 1 | -$36.4B | |
| 2 | -$1.18M | |
| 3 | -$487K | |
| 4 |
Millennium Management
New York
|
-$80.7K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$39K |